Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of human umbilical cord mesenchymal stem cells injection in fibrosing interstitial lung disease
CTR20254126Phase 2Active
- Sponsor
- Tuohua Weiye
- Start
- Dec 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in pulmonary fibrosis (PF), sponsored by Tuohua Weiye. Started Dec 2025; status: active.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on CTR20254126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254126.